Patent details

EP1556013 Title: DEFERASIROX DISPERSIBLE TABLETS

Basic Information

Publication number:
EP1556013
PCT Application Number:
PCT/EP/2003/011351
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP037693843
PCT Publication Number:
WO/2004/035026
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DEFERASIROX DISPERSIBLE TABLETS
French Title of Invention:
COMPRIMES SOLUBLES DE DEFERASIROX
German Title of Invention:
DEFERASIROX DISPERGIERBARE TABLETTE
SPC Number:

Dates

Filing date:
14/10/2003
Grant date:
13/05/2009
EP Publication Date:
13/05/2009
PCT Publication Date:
29/04/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/07/2005
EP B1 Publication Date:
13/05/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/10/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/12/2009
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
DEFFEZ Karine
Address:
France (FR)

2

Name:
CASSIERE Jean-Pierre
Address:
France (FR)

Priority

Priority Number:
0223978
Priority Date:
15/10/2002
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 9/20;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
29/09/2022
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages